Evidence map›Paper›PMID 28154097›Full record

ReviewCirculation research2017

Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Xiaoming Hu, T Michael De Silva, Jun Chen, Frank M Faraci

Abstract readReview
In one paragraph

Review in Circulation research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 256 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
256citing papers in PubMed, 5 pooled it
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

256 citing papers in PubMed, 5 syntheses or guidelines pooled it, 433 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
  8. Article
  9. Review
  10. Danshen (Antioxidants (Basel, Switzerland) · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

196 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Xiaoming HuFrom the Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh School of Medicine, PA (X.H., J.C.); Biomedicine Discovery Institute, Department of Pharmacology, Monash University, Clayton, Victoria, Australia (T.M.D.S.); and Departments of Internal Medicine and Pharmacology, Carver College of Medicine, University of Iowa, Iowa City Veterans Affairs Healthcare System (F.M.F.).
T Michael De SilvaFrom the Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh School of Medicine, PA (X.H., J.C.); Biomedicine Discovery Institute, Department of Pharmacology, Monash University, Clayton, Victoria, Australia (T.M.D.S.); and Departments of Internal Medicine and Pharmacology, Carver College of Medicine, University of Iowa, Iowa City Veterans Affairs Healthcare System (F.M.F.).
Jun ChenFrom the Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh School of Medicine, PA (X.H., J.C.); Biomedicine Discovery Institute, Department of Pharmacology, Monash University, Clayton, Victoria, Australia (T.M.D.S.); and Departments of Internal Medicine and Pharmacology, Carver College of Medicine, University of Iowa, Iowa City Veterans Affairs Healthcare System (F.M.F.).
Frank M FaraciFrom the Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh School of Medicine, PA (X.H., J.C.); Biomedicine Discovery Institute, Department of Pharmacology, Monash University, Clayton, Victoria, Australia (T.M.D.S.); and Departments of Internal Medicine and Pharmacology, Carver College of Medicine, University of Iowa, Iowa City Veterans Affairs Healthcare System (F.M.F.). frank-faraci@uiowa.edu ChenJ2@upmc.edu.
Australian Regenerative Medicine Institute · AUMonash University · AUUniversity of Pittsburgh · US

Funding

Vascular Protection During HypertensionP01HL062984 · NHLBI · UNIVERSITY OF IOWA · PI LENTZ, STEVEN R · 2000 to 2015
$22.2M
Neuroprotection in Models of Cerebral IschemiaR01NS045048 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHEN, JUN · 2003 to 2015
$3.1M
MicroRNAs and post-stroke angiogenesisR01NS091175 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHEN, JUN, YIN, KEJIE · 2015 to 2019
$2.5M
Molecular Mechanisms of Microvascular Disease in BrainR01NS096465 · NINDS · UNIVERSITY OF IOWA · PI FARACI, FRANK M · 2016 to 2020
$1.9M
Regulation of Cerebral Blood Flow by Acid-Sensing Ion Channels (ASICs)R01HL113863 · NHLBI · UNIVERSITY OF IOWA · PI FARACI, FRANK M, WEMMIE, JOHN A · 2012 to 2016
$1.9M
Mechanisms of Neurovascular Injury in Cerebral IschemiaR01NS089534 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHEN, JUN · 2014 to 2018
$1.7M
Immunomodulation of white matter integrity after strokeR01NS092618 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HU, XIAOMING · 2015 to 2020
$1.7M
White matter restoration and functional recovery after experimental strokeR01NS095671 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHEN, JUN · 2015 to 2020
$1.7M
Role of PPAR-gamma in Cerebral EndotheliumI01BX001399 · VA · IOWA CITY VA MEDICAL CENTER · PI FARACI, FRANK M · 2013 to 2018
–
Heat shock proteins and neuroprotection in cerebral ischemiaI01BX002495 · VA · VETERANS HEALTH ADMINISTRATION · PI CHEN, JUN · 2015 to 2020
–
BLRD VA I01 BX001399BLRD VA I01 BX002495NHLBI NIH HHS P01 HL062984NHLBI NIH HHS R01 HL113863NINDS NIH HHS R01 NS045048NINDS NIH HHS R01 NS089534NINDS NIH HHS R01 NS091175NINDS NIH HHS R01 NS092618NINDS NIH HHS R01 NS095671NINDS NIH HHS R01 NS096465
6 · The paper itself

Abstract

The consequences of cerebrovascular disease are among the leading health issues worldwide. Large and small cerebral vessel disease can trigger stroke and contribute to the vascular component of other forms of neurological dysfunction and degeneration. Both forms of vascular disease are driven by diverse risk factors, with hypertension as the leading contributor. Despite the importance of neurovascular disease and subsequent injury after ischemic events, fundamental knowledge in these areas lag behind our current understanding of neuroprotection and vascular biology in general. The goal of this review is to address select key structural and functional changes in the vasculature that promote hypoperfusion and ischemia, while also affecting the extent of injury and effectiveness of therapy. In addition, as damage to the blood-brain barrier is one of the major consequences of ischemia, we discuss cellular and molecular mechanisms underlying ischemia-induced changes in blood-brain barrier integrity and function, including alterations in endothelial cells and the contribution of pericytes, immune cells, and matrix metalloproteinases. Identification of cell types, pathways, and molecules that control vascular changes before and after ischemia may result in novel approaches to slow the progression of cerebrovascular disease and lessen both the frequency and impact of ischemic events.

Indexed as

AnimalsBlood-Brain BarrierBrain IschemiaCerebrovascular DisordersEndothelium, VascularHumansRisk FactorsStrokeblood-brain barriercerebrovascular circulationendotheliuminflammationpericytesrisk factors

Identifiers

PMID28154097
PMCPMC5313039
OpenAlexW2584646669

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.